Here are four notes:
1. The market will likely grow at a compound annual growth rate of 5.91 percent through 2020.
2. Outpatient spine surgery will boost the market, as it offers cost savings.
3. Spinal implant complications may hinder market growth.
4. Dominant vendors include West Chester, Pa.-based DePuy Synthes; Dublin, Ireland-based Medtronic; San Diego-based NuVasive; Kalamazoo, Mich.-based Stryker; and Warsaw, Ind.-based Zimmer Biomet.
More articles on devices:
Hip, knee orthopedic surgical implants to surge to $33B by 2022; Zimmer Biomet dominating market — 5 things to know
Bioventus appoints John Nosenzo new chief commercial officer: 7 thoughts
Xtant Medical CEO Dan Goldberger resigns: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
